Loading...
Carfilzomib
India Pharmaceutical Trade Intelligence
Who Supplies Carfilzomib to India from UNITED STATES
India's carfilzomib imports from UNITED STATES total $352.3K across 29 shipments from 11 foreign suppliers. ESPEE BIOPHARMA & FINECHEM LLC leads with $97.7K in import value; the top 5 suppliers together control 89.0% of this origin. Leading Indian buyers include DR.REDDY'S LABORATORIES LTD. This corridor reflects India's pharmaceutical import demand for carfilzomib — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
ESPEE BIOPHARMA & FINECHEM LLC is the leading Carfilzomib supplier from UNITED STATES to India, with import value of $97.7K across 1 shipments. The top 5 suppliers — ESPEE BIOPHARMA & FINECHEM LLC, Amgen Manufacturing Limited, NewLife Medicals (USA). Inc., ADIRAMEDICA LLC, JANSSEN PHARMACEUTICA NV — collectively account for 89.0% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE BIOPHARMA & FINECHEM LLC | $97.7K | 1 | 27.7% |
| 2 | Amgen Manufacturing Limited | $80.2K | 2 | 22.8% |
| 3 | NewLife Medicals (USA). Inc. | $50.0K | 6 | 14.2% |
| 4 | ADIRAMEDICA LLC | $46.5K | 3 | 13.2% |
| 5 | JANSSEN PHARMACEUTICA NV | $39.1K | 4 | 11.1% |
| 6 | NILSCH LLC | $24.5K | 2 | 7.0% |
| 7 | SUN PHARMACEUTICAL INDUSTRIES INC | $7.2K | 1 | 2.0% |
| 8 | M/S. SUN PHARMACEUTICAL INDUSTRIES | $3.8K | 1 | 1.1% |
| 9 | Celtis Healthcare LLC | $2.7K | 6 | 0.8% |
| 10 | NEWLIFE MEDICALS USA INC | $460 | 2 | 0.1% |
| 11 | INGENUS PHARMACEUTICALS,LLC | $40 | 1 | 0.0% |
Showing top 11 of 11 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | DR.REDDY'S LABORATORIES LTD | $151.2K | 7 | 42.9% |
| 2 | NEOVANT THERAPEUTICS PRIVATE LIMITED | $97.7K | 1 | 27.7% |
| 3 | HETERO LABS LIMITED | $50.0K | 6 | 14.2% |
| 4 | JOHNSON & JOHNSON PRIVATE LIMITED | $36.3K | 3 | 10.3% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $11.0K | 2 | 3.1% |
| 6 | JOHNSON JOHNSON PRIVATE LIMITED | $2.8K | 1 | 0.8% |
| 7 | DR REDDYS LABORATORIES LIMITED | $2.7K | 6 | 0.8% |
| 8 | EUGIA PHARMA SPECIALITIES LIMITED | $460 | 2 | 0.1% |
| 9 | RICONPHARMA INDIA PRIVATE LIMITED | $40 | 1 | 0.0% |
Import Statistics
- Import Value
- $352.3K
- Shipments
- 29
- Foreign Suppliers
- 11
- Indian Buyers
- 9
- Avg. Shipment
- $12.1K
Other Carfilzomib Import Origins
Related Analysis
Frequently Asked Questions — Carfilzomib Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Carfilzomib suppliers from UNITED STATES to India?
The top Carfilzomib suppliers from UNITED STATES to India include ESPEE BIOPHARMA & FINECHEM LLC, Amgen Manufacturing Limited, NewLife Medicals (USA). Inc.. The leading supplier is ESPEE BIOPHARMA & FINECHEM LLC with import value of $97.7K USD across 1 shipments. India imported Carfilzomib worth $352.3K USD from UNITED STATES in total across 29 shipments.
QHow much Carfilzomib does India import from UNITED STATES?
India imported Carfilzomib worth $352.3K USD from UNITED STATES across 29 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Carfilzomib from UNITED STATES?
The main Indian buyers of Carfilzomib sourced from UNITED STATES include DR.REDDY'S LABORATORIES LTD, NEOVANT THERAPEUTICS PRIVATE LIMITED, HETERO LABS LIMITED. The largest buyer is DR.REDDY'S LABORATORIES LTD with $151.2K in imports across 7 shipments.
QWhat is the total value of Carfilzomib imports from UNITED STATES to India?
The total value of Carfilzomib imports from UNITED STATES to India is $352.3K USD, across 29 shipments and 11 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Carfilzomib.
- 2.Supplier/Buyer Matching: 11 foreign suppliers from UNITED STATES and 9 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $352.3K aggregated from 29 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
29 Verified Shipments
11 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists